The renin-angiotensin system antagonism in the treatment of hypertension

被引：1

作者：

Bisognano J.D. ^{[1
]}

Cody R.J. ^{[1
]}

机构：

[1] Divisions of Hypertension and Cardiology, University of Michigan Medical Center, 3918 Taubman Center, Ann Arbor, MI 48109

来源：

Current Hypertension Reports | 1999年 / 1卷 / 4期

关键词：

Angiotensin; Renin; Candesartan; Telmisartan; Irbesartan;

D O I：

10.1007/s11906-999-0033-6

中图分类号：

学科分类号：

摘要：

The effective treatment of hypertension is associated with improved mortality and morbidity from diseases such as stroke, congestive heart failure, and renal failure. Use of medications that target the renin-angiotensin system for the treatment of hypertension can often achieve the desired decrease in blood pressure while causing a minimum of unwanted side effects. In this paper, the principles of the renin-angiotensin system antagonism are described. The approach to using these medications is discussed with special attention to specific indications as well as common side effects. Copyright © 1999 by Current Science Inc.

引用

页码：275 / 277

页数：2

共 13 条

[11]

Wagstaff A.J., Davis R., McTavish D., Fosinopril: A reappraisal of its pharmacology and therapeutic efficacy in essential hypertension, Drugs, 51, pp. 777-791, (1996)

[12]

Goodfriend T.L., Elliott M.E., Catt K.J., Angiotensin receptors and their antagonists, N Engl J Med, 334, pp. 1649-1654, (1996)

[13]

Hanssens M., Keirse M.J., Vankelecom F., Van Assche F.A., Fetal and neonatal effects of treatment with angiotensinconverting enzyme inhibitors in pregnancy, Obstet Gynecol, pp. 128-135, (1991)

← 1 2 →